Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Feldman DN et al. – The results of this meta–analysis in a PAD cohort revealed that treatment with aspirin did not significantly reduce the combined end point of cardiovascular events; however, aspirin resulted in a significant reduction in the incidence of nonfatal stroke. This analysis raises a number of questions regarding the overall efficacy of aspirin in PAD and what should be the optimal antiplatelet therapy in patients with PAD: aspirin, clopidogrel or perhaps a combination of aspirin and clopidogrel.


   

Related Articles

Embracing the palliative care aspects of peripheral artery disease (PAD): the vascular surgeon's perspective
Progress in Palliative Care, 10/01/09    Relevance Score: 83%

Fasting Not Necessary for Some Vascular Disease Tests
Ivanhoe, 11/17/09    Relevance Score: 82%

Regenerative Therapy in Peripheral Artery Disease
Cardiovascular Drug Reviews, 11/13/09    Relevance Score: 82%

Women and peripheral arterial disease
Women's Health, 10/30/09    Relevance Score: 82%

Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
Circulation, 10/12/09    Relevance Score: 81%

Today in Clinical Pharmacology...keeping you current

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise
Internal Medicine Journal, 03/19/10

Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/19/10

Today in Vascular Medicine...keeping you current

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Circulating microparticles may influence early carotid artery remodeling
Journal of Hypertension, 03/19/10

Advances in the treatment of Raynaud’s phenomenon
Vascular Health and Risk Management, 03/19/10

Today in Clinical Pharmacology...keeping you current

Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/19/10

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Today in Clinical Pharmacology...keeping you current

Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/19/10

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Today in Preventive Medicine...keeping you current

Organisational travel plans for improving health
Cochrane Reviews, 03/19/10

Meta-Synthesis of Health Behavior Change Meta-Analyses
American Journal of Public Health, 03/19/10

Early-life determinants of overweight and obesity: a review of systematic reviews
Obesity Reviews, 03/19/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address